Myosin Therapeutics
Myosin Therapeutics is a biotechnology company developing novel therapies for cancer and neurological disorders. They are advancing MT-125 to treat glioblastoma and MT-110 for the treatment of methamphetamine use disorder (MUD). The company is focused on developing therapies for neuroscience and oncology indications using a platform that targets molecular nanomotor proteins.
Funding Round: Seed
Funding Amount: $3M
Date: 03-Mar-2025
Investors: DeepWork Capital, Florida Opportunity Fund, Mint12 Pharma, Dynagrow Capital, Mayo Clinic Ventures, The Sontag Innovation Fund
Markets: Biotech, Oncology, Neuroscience
HQ: Jupiter, Florida, United States
Founded: 2020
Website: https://www.myosintherapeutics.com/
LinkedIn: https://www.linkedin.com/company/myosin-therapeutics-inc
Crunchbase: https://www.crunchbase.com/organization/myosin-therapeutics
Leave a Comment
Comments
No comments yet.